Dr. Srikanth M

Dr. Srikanth M
Dr. Srikanth M

Apollo Hospitals Greams Road, Chennai

Designation of Dr. Srikanth M

Dr. Srikanth M 
Hematologist
Senior Consultant
Apollo Hospitals Greams Road, Chennai

Profile Snapshot of Dr. Srikanth M

  • Dr. Srikanth M is one of the top Hematologists in Chennai with an experience of 25 years in the field. He practices as the Senior Consultant Hematologist at Apollo Hospital in Greams Road, Chennai.
  • He assists patients with an accurate diagnosis, consultation, and treatment for Hemophilia, Leukemia, Myeloma, Thalassemia, Lymphoma, and other blood diseases. The doctor also offers Bone Marrow Transplant and Chelation Therapy, etc.
  • Dr. Srikanth M has completed MRCP from the Royal College of Physicians, London to enhance his skills and received a fellowship from Royal Marsden Hospital.
  • He has contributed many articles and research papers to various publications.

Dr. M Srikanth’s Expertise

Work Experience of Dr. Srikanth M

  • An overall 25 years of experience
  • Senior Consultant – Hematology at Apollo Hospital, Chennai
  • Royal Marsden Hospital
  • St George Health Care, London
  • Hammersmith Hospital, London
  • Institute of Cancer Research, UK

Dr. M Srikanth’s Qualifications

  • MBBS from KMC
  • MD (General Medicine) from University College London, UK in 2011
  • MRCP (UK) from Royal College Of Physician, London in 2000
  • Diploma RCPath (UK)
  • CCT (UK), Hematology

Memberships of Dr. Srikanth M

  • American Society of Hematology
  • Royal College Of Pathologists, UK
  • British Society of Hematology
  • European Society of Hematology
  • Royal College of Physicians, United Kingdom
  • Awards & Achievements
  • GCRF Fellowship Awarded By Royal Marsden Hospital UK For Performing Research On Multiple Myeloma
  • MD Drug Development In Multiple Myeloma from University Of London UK

Publications of Dr. Srikanth M

  • Moore HE, Davenport EL, Smith EM, Muralikrishnan S, Dunlop AS, Walker BA, Krige D, Drummond AH, Hooftman L, Morgan GJ, Davies FE. Aminopeptidase Inhibition as a Targeted Treatment Strategy in Myeloma. Molecular Cancer Therapy, 2009: 762-770
  • Autophagy is a key myeloma survival pathway that can be manipulated therapeutically to enhance apoptosis; Blood 2010: 408

Contact us

Thank you!

Hi!
Thanks for for contacting! We will get back to you at the earliest possible.
For quicker response, you may also chat with us using the WhatsApp chat button below the page.
 
Connect on Telegram!